Hiroto Inaba - Concepedia

Author

Hiroto Inaba

St. Jude Children's Research Hospital ORCID

Also Known As

Charles Mullighan, Clifford Takemoto, H Inaba, H. Inaba, HIROTO INABA, Hiroto Inaba, Hiroto Inaba (482836), Hiroto Inaba, Hiroki Hori, Masahiro, Raul Ribeiro, Scott Howard

477

Publications

13.2K

Citations

H-Index

104

Concepts

All Affiliations

St. Jude Children's Research Hospital University of Tennessee Health Science Center National University of Singapore Mie University The University of Texas MD Anderson Cancer Center

About

Hiroto Inaba is an author at St. Jude Children's Research Hospital specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	36	4.2K
2	Health Sciences	7	7	863
3	Public Health	2	2	228
4	Education	1	1	100
5	Engineering	1	1	75

Hiroto Inaba

132

Publications

9.4K

Citations

H-Index

Page 1

	Year	Citations
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia Jeffrey E. Rubnitz, Hiroto Inaba, Raul C. Ribeiro, Journal of Clinical Oncology Hematological MalignancyCell TherapyTransplantationMarrow TransplantationAcute Myeloid Leukemia	2010	638
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial Jeffrey E. Rubnitz, Hiroto Inaba, Gary V. Dahl, The Lancet Oncology Hematological MalignancyPediatric HematologyMedicineMixed-phenotype Acute LeukemiaHematology	2010	571
Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia Deepa Bhojwani, Noah D. Sabin, Deqing Pei, Journal of Clinical Oncology	2014	370
The genetic basis and cell of origin of mixed phenotype acute leukaemia Thomas Alexander, Zhaohui Gu, Ilaria Iacobucci, Nature Hematological MalignancyMixed-phenotype Acute LeukemiaGeneticsMalignant Blood DisorderImmunology	2018	358
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16 Sima Jeha, Deqing Pei, John Choi, Journal of Clinical Oncology	2019	255
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia Hiroto Inaba, Elaine Coustan‐Smith, Xueyuan Cao, Journal of Clinical Oncology	2012	206
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Patrick A. Brown, Hiroto Inaba, Colleen Annesley, Journal of the National Comprehensive Cancer Network Hematological MalignancyTranslational MedicineOncologyTransplantationPediatric Hematology	2020	204
Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study Ching‐Hon Pui, Deqing Pei, Elaine Coustan‐Smith, The Lancet Oncology Hematological MalignancyPrognostic EvaluationPediatric HematologyMedicineClinical Utility	2015	203
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer Hiroto Inaba, Raja B. Khan, Fred H. Laningham, Annals of Oncology Neuro-oncologyOncologyPediatric HematologyPediatric PatientsRadiological Characteristics	2007	192
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia Wing Leung, Ching‐Hon Pui, Elaine Coustan‐Smith, Blood	2012	186

Page 1